Meeting
2022 ASCO Quality Care Symposium
The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting.
Authors
Fauzia Riaz
Stanford University, Division of Oncology, Stanford, CA
Fauzia Riaz, Huili Zhu, Wei Cheng, Samantha Brongiel, Elena Baldwin, Melanie Wain Kier, Jacob Zaemes, Caleb Hearn, Osama Abdelghany, Ravi Bharat Parikh, Joshua E. Reuss, Elizabeth Horn Prsic, Deborah Blythe Doroshow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Patient Safety
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 300)
DOI
10.1200/JCO.2022.40.28_suppl.300
Abstract #
300
Poster Bd #
A3
Abstract Disclosures
Similar Posters
First Author: Hazel O'Sullivan
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
First Author: Laurent Mhanna
Poster
2022 ASCO Annual Meeting
A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma.
First Author: Sophia Z. Shalhout
Poster
2020 ASCO Quality Care Symposium
Effectiveness of immunotherapy given to cancer patients in the hospitalized setting.
First Author: Mojisola O Araoye